About LinkDoc Technology
LinkDoc Technology is a data-driven, AI-enabled medical technology company operating in the healthcare and technology sectors. The company offers a range of services including big data processing, AI diagnosis and treatment, clinical trial matching, and digital therapeutics, all aimed at improving patient care and facilitating medical research. Its primary customers are in the healthcare industry, including pharmaceutical companies, medical institutions, insurance organizations, and administrative regulatory departments. It was founded in 2014 and is based in Beijing, Beijing.
LinkDoc Technology's Product Videos
LinkDoc Technology's Products & Differentiators
We are devoted to advancing state-of-the-art medical data technology, processes and analytics to unlock the critical data bottleneck in healthcare by generating high-quality data with transformative efficiency, quality and accuracy. We have developed industry-leading and differentiated technologies and have built the largest oncology patient cohorts in China capable of integrating clinical, genomic and outcome data on the individual level to systematize raw patient data at a new level of efficiency and accuracy.
Expert Collections containing LinkDoc Technology
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
LinkDoc Technology is included in 5 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Digital Health 150
The most promising digital health startups transforming the healthcare industry
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.
Latest LinkDoc Technology News
Sep 10, 2021
WeRide launches first L4 self-driving cargo van Chinese autonomous driving technology developer WeRide launched its first L4-level self-driving cargo van yesterday and announced that it will work with Jiangling Motors, a major Chinese automobile manufacturer, and ZTO Express, a leading express delivery company in China, to drive mass production and the commercialization of the newly unveiled WeRide Robovan. Robovan’s design is based on Jiangling’s battery electric vehicle model, equipped with WeRide’s full-stack software and hardware solutions. LinkDoc plans to raise US$300 million before HK IPO Alibaba-backed medical information platform LinkDoc Technology will start a new round of financing before Hong Kong IPO, and plans to raise US$300 million. AR company HiScene completes a RMB270 million series C+ round AR technology company HiScene announced the completion of a RMB270 million series C+ round financing. The new round was led by CITIC PE, with participation from Jadex Capital, Yuanhui Capital and other existing investors such as V Star Capital, Xinxi Capital, Ondice Capital, MYEG, etc. After this round of financing, the company will continue to rely on AR/AI technologies such as space computing, AR cloud, natural interaction and AR smart hardware to strengthen and upgrade the AR platform HiAR Space and accelerate application of their products and services in vertical industries. Canalys: Only 10% of every 1 billion cars in use are equipped with ADAS Global market research firm Canalys released the latest research report, pointing out that by the end of 2020, only 10% of every 1 billion vehicles in use worldwide are equipped with advanced driver assistance systems (ADAS). Currently, in major markets such as China, Europe, Japan, and the United States, one-third of new cars have been equipped with ADAS functions. However, it will take several years to complete the equipment on half of the cars in use worldwide. CICC: Internet of Everything opens a new decade, the growth of consumer-level AIoT is expected According to CICC’s research report, with the maturity of underlying technologies such as 5G and AI, they look forward to the gradual prosperity of next-generation applications represented by wearable devices, AR/VR, smart homes and smart cars. CICC is optimistic about the Internet of Everything (IoE) to take over smart phones and start the next decade of consumer electronics innovation cycle. Under the influence of factors such as the increase in the number of IoT connections, the slowdown of smartphone innovation, and the dual drive of hardware and scenario, the interactive models of electronic products are expected to usher in new iterations and updates, and the growth of consumer-level AIoT era is expected. (China Money Network’s articles are curated and translated from credible Chinese media organizations with established brands, experienced editorial teams, and trustworthy journalism practices. However, we are not responsible for the accuracy of the information. For any questions, please reach out to our editorial department.)
LinkDoc Technology Frequently Asked Questions (FAQ)
When was LinkDoc Technology founded?
LinkDoc Technology was founded in 2014.
Where is LinkDoc Technology's headquarters?
LinkDoc Technology's headquarters is located at 11/F, China Steel International Plaza, Beijing.
What is LinkDoc Technology's latest funding round?
LinkDoc Technology's latest funding round is Corporate Minority.
How much did LinkDoc Technology raise?
LinkDoc Technology raised a total of $253.02M.
Who are the investors of LinkDoc Technology?
Investors of LinkDoc Technology include Alibaba Health, China Broadband Capital, China Capital Investment Group, Youshan Capital, China Investment Corporation and 7 more.
Who are LinkDoc Technology's competitors?
Competitors of LinkDoc Technology include Jingli Technology and 7 more.
What products does LinkDoc Technology offer?
LinkDoc Technology's products include Data Curation and 2 more.
Compare LinkDoc Technology to Competitors
General Prognostics is a developer of bloodless blood tests for remote chronic disease management. The company was founded in 2020 and is based in Boston, Massachusetts.
Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.
Global Blood Resources is a company that is making advances in whole blood recovery, salvaging, and transfusions.Their main product is the Hemobag which is a device that returns a patient's own blood to their body during invasive surgery. This product is an alternative to risky transfusions.
Rafael Medical has developed a novel anchoring system for safely implanting and retrieving a wide range of intra-vascular devices in a minimally invasive manner. Based on the technology, diagnostic and therapeutic devices can be delivered into small and large blood vessels alike by way of a small-sized delivery system. Following the completion of the SafeFlo Filter the company is now developing additional devices geared to the interventional cardiology market.
Tayside Flow Technologies Limited is a medical device company. It had developed the Spiral Laminar Flow Vascular Arteriovenous Graft.Tayside Flow Technologies Ltd (TFT) is a medical technology company focussed on the development of cardiovascular devices based on a new understanding of blood flow dynamics, Spiral Laminar Flow.
FIRE1 (Foundry Innovation & Research 1) provides healthcare and medical device solutions. The company focuses on developing novel remote monitoring devices. The company helps to improve patient quality of life and outcomes for those suffering from chronic diseases and reduce the burden of heart failure. FIRE1 was founded in 2016 and is based in Dublin11, Ireland.